中国体外循环杂志2023，Vol.21Issue(6)：376-380,5.DOI:10.13498/j.cnki.chin.j.ecc.2023.06.14
冠心病左主干和(或)三支病变介入治疗与冠脉旁路移植的比较研究进展
The advances of interventional therapy and coronary artery bypass grafting for left main and/or triple vessel disease of coronary artery disease
摘要
Abstract
Coronary artery bypass grafting(CABG)has been the preferred choice of treatment for left main coronary ar-tery disease(LMCAD)and triple vessel disease(TVD)for quite long time.In recent years,due to the rapid development of endo-luminal imaging technology and the introduction of novel coronary artery stents,percutaneous coronary intervention(PCI)has become one of the alternative treatment choice for LMCAD and TVD as the long-term patency and target vessel revascularisa-tion rates have been improved compared with the previous ones.But there is still no international consensus on therapeutic deci-sion-making for LMCAD and TVD lesions.This paper summarizes the available evidence on the long-term outcomes of these two therapeutic strategies for LMCAD and TVD lesions in order to aid clinical decision-making and improve the therapeutic ef-fect.关键词
冠状动脉粥样硬化性心脏病/左主干病变/多支血管病变/冠状动脉旁路移植术/经皮冠状动脉介入治疗Key words
Coronary artery disease/Left main coronary artery disease/Multivessel coronary artery disease/Coronary artery bypass grafting/Percutaneous coronary intervention引用本文复制引用
杨坤,邓勇志..冠心病左主干和(或)三支病变介入治疗与冠脉旁路移植的比较研究进展[J].中国体外循环杂志,2023,21(6):376-380,5.基金项目
山西省重点研发计划资助项目(Grant No:201903D321176) （Grant No:201903D321176）
